| Literature DB >> 22957007 |
Chun-Ming Chang1, Yu-Chieh Su, Ning-Sheng Lai, Kuang-Yung Huang, Sou-Hsin Chien, Yu-Han Chang, Wei-Cheng Lian, Ta-Wen Hsu, Ching-Chih Lee.
Abstract
BACKGROUND: This population-based study investigated the relationship between individual and neighborhood socioeconomic status (SES) and mortality rates for major cancers in Taiwan.Entities:
Mesh:
Year: 2012 PMID: 22957007 PMCID: PMC3431308 DOI: 10.1371/journal.pone.0044325
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics (n = 20488).
| Variables | Age <65 years (n = 12382) | Age ≧65 years (n = 8106) | ||||||||||||
| High SES | Moderate SES | Low SES | p value | High SES | Moderate SES | Low SES | p value | |||||||
| (n = 1626) | (n = 2823) | (n = 7933) | (n = 314) | (n = 607) | (n = 7185) | |||||||||
| Mean age, years (±SD) | 52 | ±7.9 | 51 | ±8.7 | 50 | ±9.2 | <0.001 | 70 | ±4.8 | 70 | ±3.7 | 75 | ±6 | <0.001 |
| Gender | <0.001 | <0.001 | ||||||||||||
| Male (%) | 965 | (59.3) | 1322 | (46.8) | 3618 | (45.6) | 36 | (11.5) | 111 | (18.3) | 2285 | (31.8) | ||
| Female (%) | 661 | (40.7) | 1501 | (53.2) | 4315 | (54.6) | 278 | (88.5) | 496 | (81.7) | 4900 | (68.2) | ||
| Urbanization | <0.001 | <0.001 | ||||||||||||
| Urban (%) | 643 | (39.5) | 1101 | (39.0) | 2111 | (26.6) | 133 | (42.4) | 236 | (38.9) | 1282 | (17.8) | ||
| Suburban (%) | 746 | (45.9) | 1341 | (47.5) | 3615 | (45.6) | 129 | (41.1) | 276 | (45.5) | 2665 | (37.1) | ||
| Rural (%) | 237 | (14.6) | 380 | (13.5) | 2207 | (27.8) | 52 | (16.6) | 95 | (15.7) | 3238 | (45.1) | ||
| Geographic Region | <0.001 | <0.001 | ||||||||||||
| Northern (%) | 966 | (16.4) | 1628 | (57.7) | 3288 | (41.4) | 187 | (59.6) | 384 | (63.3) | 2571 | (35.8) | ||
| Central (%) | 383 | (11.8) | 727 | (25.6) | 2138 | (26.9) | 73 | (23.2) | 127 | (20.9) | 2101 | (29.2) | ||
| Southern/Eastern (%) | 277 | (8.5) | 471 | (16.7) | 2511 | (31.7) | 54 | (17.2) | 96 | (15.8) | 2513 | (35.0) | ||
| Charlson Comorbidity Index Score | 0.564 | 0.183 | ||||||||||||
| 0 (%) | 909 | (55.9) | 1627 | (57.6) | 4533 | (57.1) | 155 | (49.4) | 290 | (47.8) | 3306 | (46.0) | ||
| 1–6 (%) | 519 | (31.9) | 864 | (30.6) | 2464 | (31.1) | 110 | (35.0) | 218 | (35.9) | 2657 | (37.0) | ||
| >6 (%) | 198 | (12.2) | 332 | (11.8) | 936 | (11.8) | 49 | (15.6) | 99 | (16.3) | 1222 | (17.0) | ||
| Tumor stage | 0.026 | 0.428 | ||||||||||||
| Local, locoregional tumor (%) | 1418 | (87.2) | 2529 | (89.6) | 7100 | (89.5) | 265 | (84.4) | 503 | (82.9) | 6089 | (84.7) | ||
| Distant metastatic tumor (%) | 208 | (12.8) | 294 | (10.4) | 833 | (10.5) | 49 | (15.6) | 104 | (17.1) | 1096 | (15.3) | ||
| Surgery | 0.017 | 0.002 | ||||||||||||
| Yes (%) | 1067 | (65.6) | 1863 | (66.0) | 5031 | (63.4) | 164 | (52.2) | 305 | (50.2) | 3262 | (45.4) | ||
| No (%) | 559 | (34.4) | 960 | (34.0) | 2902 | (36.6) | 150 | (47.8) | 302 | (49.8) | 3923 | (54.6) | ||
| Nonsurgical Therapy | 0.045 | 0.239 | ||||||||||||
| Nil (%) | 721 | (44.3) | 1250 | (44.3) | 3384 | (42.7) | 178 | (56.7) | 350 | (57.7) | 4570 | (63.6) | ||
| Radiotherapy (%) | 222 | (13.7) | 355 | (12.6) | 1086 | (13.7) | 48 | (15.3) | 83 | (13.7) | 811 | (11.3) | ||
| Chemotherapy (%) | 354 | (21.8) | 625 | (22.1) | 1701 | (21.4) | 62 | (19.7) | 102 | (16.8) | 1160 | (16.1) | ||
| Chemoradiotherapy (%) | 329 | (20.2) | 593 | (21.0) | 1762 | (22.2) | 26 | (8.3) | 72 | (11.9) | 644 | (9.0) | ||
| Hospital characteristics | ||||||||||||||
| Teaching level | <0.001 | <0.001 | ||||||||||||
| Medical center (%) | 1133 | (69.7) | 1922 | (68.1) | 5262 | (66.3) | 226 | (72.0) | 378 | (62.3) | 4104 | (57.1) | ||
| Regional (%) | 440 | (27.1) | 763 | (27.0) | 2251 | (28.4) | 77 | (24.5) | 187 | (30.8) | 2352 | (32.7) | ||
| District (%) | 53 | (3.3) | 138 | (4.9) | 420 | (5.3) | 11 | (3.5) | 42 | (6.9) | 729 | (10.1) | ||
| Ownership | <0.001 | <0.001 | ||||||||||||
| Public (%) | 642 | (39.5) | 992 | (35.1) | 2441 | (30.8) | 149 | (47.5) | 255 | (42.0) | 2611 | (36.3) | ||
| Non-for-profit (%) | 738 | (45.4) | 1340 | (47.5) | 3947 | (49.8) | 119 | (37.9) | 259 | (42.7) | 3188 | (44.4) | ||
| For-profit (%) | 246 | (15.1) | 491 | (17.4) | 1545 | (19.5) | 46 | (14.6) | 93 | (15.3) | 1386 | (19.3) | ||
Abbreviation: SES, socioeconomic status.
Figure 1Rates of use of treatment in cancer patient aged less than 65 years (a) and those aged 65 years and above (b).
Figure 2The combined effect of individual and neighborhood SES on cancer survival rates in patients aged less than 65 years (a) and those aged 65 years and above (b).
Combined effect of individual SES and neighborhood SES on 5-year overall survival rates(n = 20488).
| Neighborhoodsocioeconomic status | Individual socioeconomic status | ||||||||
| Age <65 years (n = 12382) | Age ≧65 yeasr (n = 8106) | ||||||||
| High SES | Moderate SES | Low SES | High SES | Moderate SES | Low SES | ||||
| (%) | (%) | (%) | p value | (%) | (%) | (%) | p value | ||
| Lung cancer (n = 4698) | n = 1984 | 0.001 | n = 2714 | <0.001 | |||||
| Advantaged | 29.4 | 25.4 | 20.9 | 23.6 | 18.1 | 20.2 | |||
| Disadvantaged | 35.3 | 25.8 | 22.5 | 21.9 | 28.3 | 17.0 | |||
| Colorectal cancer (n = 5135) | n = 2536 | 0.005 | n = 2599 | 0.023 | |||||
| Advantaged | 66.7 | 66.7 | 59.4 | 54.1 | 64.1 | 53.9 | |||
| Disadvantaged | 66.7 | 67.8 | 59.0 | 56.0 | 44.4 | 50.3 | |||
| Breast cancer (n = 3581) | n = 3223 | 0.079 | n = 358 | 0.895 | |||||
| Advantaged | 88.1 | 85.9 | 82.9 | 70.0 | 85.7 | 72.4 | |||
| Disadvantaged | 87.4 | 84.3 | 81.9 | 66.7 | 76.9 | 71.0 | |||
| Cervical cancer (n = 1346) | n = 1066 | 0.262 | n = 280 | 0.263 | |||||
| Advantaged | 85.7 | 73.8 | 73.4 | 50.0 | 90.0 | 60.8 | |||
| Disadvantaged | 86.7 | 79.5 | 78.8 | 0.0 | 50.0 | 51.1 | |||
| Prostate cancer (n = 1247) | n = 204 | 0.143 | n = 1043 | <0.001 | |||||
| Advantaged | 85.4 | 77.4 | 80.0 | 84.4 | 73.4 | 64.5 | |||
| Disadvantaged | 84.4 | 76.5 | 64.2 | 80.8 | 89.3 | 53.3 | |||
| Head and neck cancer (n = 3770) | n = 3053 | 0.001 | n = 717 | 0.152 | |||||
| Advantaged | 71.5 | 61.5 | 55.7 | 60.0 | 48.9 | 50.0 | |||
| Disadvantaged | 60.6 | 59.8 | 55.3 | 64.5 | 44.0 | 42.1 | |||
| Pancreas cancer (n = 711) | n = 316 | 0.008 | n = 395 | 0.448 | |||||
| Advantaged | 23.7 | 24.5 | 36.5 | 50.0 | 28.6 | 16.6 | |||
| Disadvantaged | 15.0 | 31.0 | 17.9 | 0.0 | 20.0 | 47.8 | |||
Abbreviation: 95% CI, 95% confidence interval.
In female breast cancer, the p-value of survival rates between the patients in high individual SES in advantaged neighborhoods and patients in low SES in disadvantaged neighborhoods was 0.014.
Hazard ratios of individual SES for mortality in advantaged and disadvantaged neighborhoods*.
| Neighborhoodsocioeconomicstatus | Individual socioeconomic status | ||||||||||||
| Age <65 years (n = 12382) | Age ≧65 years (n = 8106) | ||||||||||||
| High SES | Moderate SES | Low SES | High SES | Moderate SES | Low SES | ||||||||
| AdjustedHR | 95%CI | AdjustedHR | 95% of CI | AdjustedHR | 95%CI | AdjustedHR | 95%CI | AdjustedHR | 95%CI | AdjustedHR | 95%CI | ||
| Lung cancer (n = 4698) | n = 1984 | n = 2714 | |||||||||||
| Advantaged | 1.00 | 1.13 | (0.90–1.42) | 1.36 | (1.10–1.67) | 1.00 | 1.03 | (0.72–1.48) | 0.92 | (0.67–1.26) | |||
| Disadvantaged | 0.91 | (0.68–1.22) | 1.24 | (0.96–1.60) | 1.23 | (1.00–1.52) | 0.83 | (0.51–1.37) | 0.84 | (0.55–1.29) | 1.03 | (0.76–1.41) | |
| Colorectal cancer (n = 5135) | n = 2536 | n = 2599 | |||||||||||
| Advantaged | 1.00 | 1.06 | (0.81–1.37) | 1.40 | (1.11–1.77) | 1.00 | 0.80 | (0.51–1.26) | 0.96 | (0.68–1.37) | |||
| Disadvantaged | 0.84 | (0.59–1.18) | 1.11 | (0.81–1.52) | 1.45 | (1.14–1.83) | 1.16 | (0.58–2.29) | 1.41 | (0.88–2.27) | 1.07 | (0.75–1.53) | |
| Breast cancer (n = 3581) | n = 3223 | n = 358 | |||||||||||
| Advantaged | 1.00 | 1.38 | (0.93–2.05) | 1.70 | (1.18–2.44) | 1.00 | 0.53 | (0.08–3.60) | 0.97 | (0.26–3.65) | |||
| Disadvantaged | 1.06 | (0.57–1.94) | 1.59 | (0.99–2.55) | 1.63 | (1.13–2.36) | 1.71 | (0.16–18.15) | 1.13 | (0.21–6.22) | 1.31 | (0.34–5.14) | |
| Cervical cancer (n = 1346) | n = 1066 | n = 280 | |||||||||||
| Advantaged | 1.00 | 1.22 | (0.51–2.94) | 1.11 | (0.48–2.56) | 1.00 | 0.34 | (0.03–4.41) | 1.42 | (0.28–7.18) | |||
| Disadvantaged | 0.57 | (0.11–2.86) | 0.79 | (0.31–2.05) | 0.87 | (0.38–2.01) | 11.41 | (0.83–156.48) | 5.74 | (0.46–71.64) | 1.27 | (0.26–6.17) | |
| Prostate cancer (n = 1247) | n = 204 | n = 1043 | |||||||||||
| Advantaged | 1.00 | 1.16 | (0.37–3.65) | 0.80 | (0.23–2.78) | 1.00 | 1.99 | (0.82–4.81) | 1.78 | (0.83–3.83) | |||
| Disadvantaged | 0.81 | (0.23–2.81) | 1.64 | (0.45–6.01) | 1.80 | (0.65–4.95) | 1.23 | (0.39–3.91) | 0.79 | (0.21–3.08) | 2.54 | (1.19–5.44) | |
| Head and neck cancer (n = 3770) | n = 3053 | n = 717 | |||||||||||
| Advantaged | 1.00 | 1.61 | (1.16–2.24) | 1.98 | (1.47–2.67) | 1.00 | 1.55 | (0.63–3.85) | 1.18 | (0.51–2.74) | |||
| Disadvantaged | 1.53 | (1.04–2.25) | 1.84 | (1.30–2.59) | 2.08 | (1.55–2.79) | 0.99 | (0.30–3.31) | 142 | (0.54–3.74) | 1.55 | (0.68–3.58) | |
| Pancreas cancer (n = 711) | n = 316 | n = 395 | |||||||||||
| Advantaged | 1.00 | 0.89 | (0.54–1.47) | 0.66 | (0.42–1.06) | 1.00 | 1.95 | (0.55–6.98) | 2.19 | (0.68–7.10) | |||
| Disadvantaged | 1.15 | (0.63–2.10) | 0.82 | (0.46–1.48) | 1.31 | (0.84–2.04) | 3.94 | (0.89–17.46) | 2.66 | (0.57–12.32) | 2.26 | (0.71–7.27) | |
Abbreviation: Adjusted HR, adjusted hazard ratio; 95% CI, 95% confidence interval; SES, socioeconomic status.
Adjusted for the patients’ diagnosed age, gender, Charlson Comorbidity Index Score, tumor stage (local and locoregional versus distant metastasis), treatment modality (surgery versus without surgery), nonsurgical treatment (radiotherapy, chemotherapy, or chemoradiotherapy), and hospital characteristics (teaching level, and ownership).
Sociodemographic characteristics by individual and neighborhood socioeconomic status.
| High individual SES | Moderate individual SES | Low individual SES | p value | ||||
| Advantaged neighborhood | Disadvantaged neighborhood | Advantaged neighborhood | Disadvantaged neighborhood | Advantaged neighborhood | Disadvantaged neighborhood | ||
|
| |||||||
| Number of patients | 1032 | 594 | 1854 | 969 | 3998 | 3935 | |
| Number of deaths (%) | 334(32) | 220(37) | 649(35) | 363(38) | 1576(39) | 1660(42) | <0.001 |
| Mean age, mean±SD | 51±8 | 52±8 | 51±9 | 51±8 | 49±9 | 51±9 | <0.001 |
| Male gender, % | 563(55) | 402(68) | 818(44) | 504(52) | 1627(41) | 1991(51) | <0.001 |
| Education≧high school, % | 64% | 54% | 63% | 54% | 62% | 51% | <0.001 |
| Median household income, NT$1000 | 630±77 | 494±30 | 610±70 | 491±32 | 596±62 | 480±35 | <0.001 |
| Health care-related resources | |||||||
| Physicians per 10,000 persons, mean±SD | 28±23 | 12±13 | 25±22 | 12±12 | 23±19 | 11±11 | <0.001 |
| Pharmacies, mean±SD | 55±35 | 21±24 | 50±33 | 24±25 | 53±33 | 19±24 | <0.001 |
|
| |||||||
| Number of patients | 209 | 105 | 411 | 196 | 2863 | 4322 | |
| Number of deaths (%) | 97(46) | 53(51) | 209(51) | 103(53) | 1600(56) | 2725(63) | <0.001 |
| Mean age, mean±SD | 71±5 | 69±4 | 70±4 | 70±3 | 75±6 | 75±6 | <0.001 |
| Male gender, % | 183(88) | 95(91) | 335(82) | 161(82) | 2105(74) | 2795(65) | <0.001 |
| Education≧high school, % | 64% | 53% | 64% | 54% | 62% | 49% | <0.001 |
| Median household income, NT$1000 | 620±72 | 489±32 | 620±76 | 491±30 | 598±64 | 472±36 | <0.001 |
| Health care-related resources | |||||||
| Physicians per 10,000 persons, mean±SD | 29±22 | 12±12 | 26±22 | 12±11 | 21±18 | 9±10 | <0.001 |
| Pharmacies, mean±SD | 52±34 | 18±24 | 49±33 | 22±24 | 45±33 | 11±18 | <0.001 |
Pearson’s chi-square test.